These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 213406)

  • 21. Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and its modification by propranolol.
    Sodicoff M; Conger AD
    Radiat Res; 1983 Apr; 94(1):97-104. PubMed ID: 6304806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection.
    Varghese JJ; Schmale IL; Mickelsen D; Hansen ME; Newlands SD; Benoit DSW; Korshunov VA; Ovitt CE
    J Dent Res; 2018 Oct; 97(11):1252-1259. PubMed ID: 29634396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of microcirculation in rat brain against late radiation injury by gammaphos.
    Plotnikova ED; Levitman MK; Shaposhnikova VV; Koshevoy JuV ; Eidus LK
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):365-8. PubMed ID: 6323365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of gammaphos (WR-2721) on survival in combined radiation injuries].
    Simović M; Erdeljan D; Pantelić D; Dekić M
    Vojnosanit Pregl; 1987; 44(2):99-106. PubMed ID: 3037790
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules.
    Milas L; Hunter N; Reid BO
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):535-8. PubMed ID: 6286549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term radioprotective effects of WR-2721 on the rat parotid glands.
    Sodicoff M; Conger AD; Trepper P; Pratt NE
    Radiat Res; 1978 Aug; 75(2):317-26. PubMed ID: 213806
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
    Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1982 May; 45(5):684-93. PubMed ID: 6282299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic factors affecting the radioprotective effectiveness of phosphorothioates.
    Yuhas JM
    Experientia Suppl; 1977; 27():63-70. PubMed ID: 192569
    [No Abstract]   [Full Text] [Related]  

  • 30. Time dependence of interaction of misonidazole and WR-2721.
    Rojas A; Denekamp J
    Br J Radiol; 1983 Aug; 56(668):592-5. PubMed ID: 6307457
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration and degree of radioprotection of WR-2721 in mice following its intraperitoneal, intramuscular and subcutaneous administration.
    Kuna P
    Radiobiol Radiother (Berl); 1983; 24(3):357-64. PubMed ID: 6314424
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL; De Luca AM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the toxicity and radioprotective effect of the chemical radioprotector WR 2721 in dogs (beagles). Part 2: Radioprotective effect of WR 2721 (author's transl)].
    Wagner M; Sedlmeier H; Metzger E; Wustrow T; Messerschmidt O
    Strahlentherapie; 1980 Sep; 156(9):655-62. PubMed ID: 6254212
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of WR-2721.
    Shaw LM; Glover D; Turrisi A; Brown DQ; Bonner HS; Norfleet AL; Weiler C; Glick JH; Kligerman MM
    Pharmacol Ther; 1988; 39(1-3):195-201. PubMed ID: 2849123
    [No Abstract]   [Full Text] [Related]  

  • 35. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.
    Utley JF; Marlowe C; Waddell WJ
    Radiat Res; 1976 Nov; 68(2):284-91. PubMed ID: 185642
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatments.
    Stewart FA; Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):507-13. PubMed ID: 6303992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1731-6. PubMed ID: 6315650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation.
    Meistrich ML; Finch MV; Hunter N; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2099-107. PubMed ID: 6092308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioprotective effectiveness of amifostine on the salivary glands of the rat during fractionated irradiation].
    Sagowski C; Wenzel S; Neumann B; Kehrl W; Zywietz F; Roeser K; Ussmüller J
    HNO; 2002 Feb; 50(2):139-45. PubMed ID: 12080624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WR-2721: enhanced chemoprotection by increasing cyclophosphamide activation with phenobarbitol.
    Glover DJ; Yuhas JM; Glick JH
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):571-4. PubMed ID: 6286555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.